Once there, they may encourage the growth of new brain cells, adjust chemical signals between neurons, or help guard existing cells from harm
How does it do this
[4] [10] Nausea, vomiting, diarrhoea, and constipation were collectively experienced by a substantial proportion of participants, with higher doses associated with greater incidence and severity
Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes and chronic weight management
Proven Fat Loss
A meta-analysis of 113 RCTs comprising 33,167 patients in the GLP-1 RA cohort and 26,683 in the comparator cohort revealed no significant elevation in pancreatitis or pancreatic cancer risk relative to control groups (Mantel-Haenszel odds ratio [MH-OR] of 0.93 and 0.94, respectively), but identified a notable increase in cholelithiasis risk (MH-OR, 1.30) [58]